Advanced Search

 

Study ID Status Title Patient Level Data
S2WB3002 Completed A randomised, double-blind, placebo-controlled, oral sumatriptan-controlled (100mg), three attack, parallel group study to determine the efficacy, safety and tolerability of oral naratriptan (0.1mg, 0.25mg, 1.0mg and 2.5mg) in the acute treatment of migraine headache.
S2WB3004 Completed An open study of the long-term safety and efficacy of oral naratriptan 2.5mg in the acute treatment of migraine.
S2WB3009 Completed A study to assess the effect of 1.5mg subcutaneous naratriptan (GR85548A) on cardiac haemodynamics in patient-volunteers with existing or suspected coronary artery disease.
S2WB3011 Completed A randomised, double-blind, two attack, cross-over study to compare the efficacy, safety and tolerability of oral naratriptan 2.5mg with oral sumatriptan 100mg in the acute treatment of migraine in patients susceptible to headache recurrence.
S2WB4001 Completed A randomised double-blind, cross-over study to investigate patient overall satisfaction with efficacy and tolerability of oral Naratriptan 2.5mg Vs oral Sumatriptan 50mg for the treatment of patients who lapse from 100mg oral or 6mg subcutaneous Sumatriptan use.
S3010567 Completed A Single Dose Bioequivalence Study of 2mg and 4mg Nicotine Lozenges
S3250493 Completed Simultaneous fMRI/EEG of the 4 mg Nicotine Lozenge in Relief of Cognitive Impairment Associated with Nicotine Withdrawal
S3820642 Completed A Pharmacokinetic Evaluation of Nicotine Patches in Smokers
S3A-150 Completed An evaluation of the pharmacokinetic properties of intravenous ondansetron in children receiving chemotherapy.
S3A-154 Completed An Open Label, Randomized Evaluation of the Pharmacokinetic Properties of Intraveneous and Oral Doses of GR 38032F in Healthy, Elderly Volunteers
S3A-155 Completed An evaluation of the effect of chemotherapy on the pharmacokinetics of oral ondansetron (GR38032F).
S3A-156 Completed An evaluation of the effects of food and antacid on the absorption of oral ondansetron (GR 38032F).
S3A-157 Completed An evaluation of the steady-state pharmacokinetics of ondansetron after 1, 4 and 8 mg oral doses
S3A-158 Completed Comparison of the pharmacokinetics of ondansetron (GR38032F) in patients with various degrees of hepatic insufficiency and in normal healthy subjects.
S3A161 Completed A randomized, double-blind, placebo-controlled study of the effects of two dose levels of intravenous ondansetron on respiratory depression induced by alfentanil in healthy male volunteers.
S3A-166 Completed An evaluation of the pharmacokinetic properties of a single intravenous dose of GR38032 in healthy, adult male volunteers
S3A-171 Completed An evaluation of the effect of dosage on the pharmacokinetics of intravenous ondansetron.
S3A172 Completed An ascending dose safety and pharmacokinetic evaluation of ondansetron administered as single intravenous bolus doses to healthy male volunteers.
S3A173 Completed A dose-proportionality study of ondansetron administered as a single intravenous dose to healthy male volunteers.
S3A174 Completed A dose-proportionality study of ondansetron administered as a single oral dose (tablet) to healthy male volunteers.
S3A176 Completed Evaluation of the Effects of Cytochrome P-450 Enzyme Inducers (Carbamazepine and Phenytoin) on Ondansetron Pharmacokinetics.
S3A179 Completed Pharmacokinetics of 16 mg ondansetron suppository, 8 mg zofran tablet, and 8 mg zofran injection in healthy adult male and female subjects.
S3A20005 Completed A Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral 16MG BD Ondansetron (GR38032F) in Preventing Post-Operative Nausea and Vomiting in Patients Having General Anaesthesia and Undergoing Major Gynaecological Surgery
S3A-237 Completed Treatment of Postoperative Nausea and Vomiting: A Randomized Double-Blind Comparison of Intravenous Ondansetron and Placebo in Female Patients Undergoing Laparoscopic Procedures
S3A-241 Completed A Randomized, Double-Blind Comparison of Intravenous Ondansetron and Placebo in the Prevention of Postoperative Nausea and Vomiting in Female Patients Undergoing Laparoscopic Procedures

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.